14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 KROS stock ended at $60.57. This is 6.08% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 8.50% from a day low at $57.32 to a day high of $62.19.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Keros Therapeutics Inc. prices

Date Open High Low Close Volume
May 03, 2024 $57.32 $62.19 $57.32 $60.57 566 269
May 02, 2024 $58.34 $58.50 $56.71 $57.10 337 793
May 01, 2024 $56.66 $58.98 $55.83 $57.72 459 767
Apr 30, 2024 $57.66 $59.67 $56.22 $56.39 180 303
Apr 29, 2024 $58.39 $59.28 $57.56 $58.62 201 612
Apr 26, 2024 $54.68 $58.45 $54.14 $57.86 284 633
Apr 25, 2024 $55.05 $55.05 $53.24 $54.19 253 154
Apr 24, 2024 $55.56 $57.60 $55.56 $56.24 252 367
Apr 23, 2024 $56.15 $58.69 $54.93 $55.19 476 075
Apr 22, 2024 $58.84 $59.60 $55.54 $55.78 270 959
Apr 19, 2024 $58.54 $59.47 $56.15 $58.28 341 209
Apr 18, 2024 $59.30 $61.33 $58.15 $58.95 291 044
Apr 17, 2024 $58.56 $59.50 $56.53 $59.27 397 880
Apr 16, 2024 $57.22 $58.94 $56.59 $58.00 193 570
Apr 15, 2024 $58.90 $59.87 $57.26 $57.68 208 181
Apr 12, 2024 $61.78 $62.00 $58.08 $58.61 309 160
Apr 11, 2024 $61.55 $62.54 $61.17 $61.90 211 845
Apr 10, 2024 $61.29 $63.11 $60.39 $60.83 268 583
Apr 09, 2024 $63.41 $64.81 $61.93 $63.81 210 926
Apr 08, 2024 $63.29 $63.76 $61.05 $63.19 213 839
Apr 05, 2024 $61.63 $63.70 $60.05 $62.66 163 715
Apr 04, 2024 $64.19 $65.57 $61.25 $61.71 215 091
Apr 03, 2024 $63.46 $65.57 $63.28 $63.98 186 957
Apr 02, 2024 $65.15 $65.67 $63.11 $64.02 283 194
Apr 01, 2024 $66.11 $67.30 $64.86 $66.89 211 259
Click to get the best stock tips daily for free!

About Keros Therapeutics Inc.

Keros Therapeutics. Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in pat... KROS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT